+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Musical Groups and Artists - Global Strategic Business Report

  • PDF Icon

    Report

  • 381 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6110846
The global market for Musical Groups and Artists was valued at US$29.4 Billion in 2025 and is projected to reach US$49.9 Billion by 2032, growing at a CAGR of 7.8% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Musical Groups And Artists Market - Key Trends & Drivers Summarized

Why Are Musical Groups and Artists Adopting Business-Centric Models?

Musical groups and solo artists are undergoing a profound transformation from purely creative entities into multifaceted commercial brands. The digitization of music consumption, disintermediation of traditional record labels, and proliferation of direct-to-fan channels have altered the economics of the music industry. Artists are increasingly managing their careers as entrepreneurial ventures-balancing content creation, brand partnerships, merchandising, and touring schedules.

The rise of social media platforms like Instagram, TikTok, YouTube, and Twitch has enabled artists to build large followings, engage audiences directly, and release content on their own terms. Fan engagement has evolved beyond passive listening to interactive experiences such as livestream concerts, backstage Q&A sessions, and virtual meet-and-greets. Artists now deploy a multi-platform content strategy that includes short-form videos, behind-the-scenes footage, educational series, and lifestyle vlogs-shaping their brand narratives in real time.

In response to industry disruption, many groups and solo performers are opting for independent releases via aggregators such as TuneCore, DistroKid, and CD Baby, which offer higher revenue share and control over IP rights. Simultaneously, major labels are adapting by offering artist services, flexible contracts, and 360-degree deals that integrate streaming, publishing, merchandise, and touring under one umbrella.

How Are Artists Leveraging Technology to Build Careers and Monetize Creativity?

Technology is playing a pivotal role in enabling artists to create, distribute, and monetize their work. Home studio setups equipped with digital audio workstations (DAWs), virtual instruments, and real-time mixing tools have democratized music production. AI-assisted mastering services and beat generators are helping artists produce professional-grade tracks without needing expensive equipment or studio time. NFTs, blockchain smart contracts, and digital collectibles are emerging as new channels for fan-driven monetization, especially in hip-hop, EDM, and indie rock circles.

Crowdfunding platforms like Patreon and Kickstarter, along with membership-based models, are offering artists recurring income and a direct financial relationship with superfans. Live-streaming tools allow artists to perform remotely, sell tickets, and accept tips-extending their reach beyond geographical limitations. Data analytics dashboards from Spotify for Artists, YouTube Studio, and Bandcamp provide performance metrics, listener demographics, and revenue insights that help musicians tailor their release strategies.

Artists are also leveraging AI tools for lyric generation, beat recommendation, and real-time collaboration with remote producers. Mobile-first music creation apps like Splice, BandLab, and Soundtrap are allowing artists to compose, edit, and publish tracks from anywhere, empowering both emerging and established musicians to maintain creative momentum on the go.

Which Genres, Markets, and Platforms Are Defining the Trajectory of Artists and Bands?

The global appetite for diverse genres-from K-pop and Afrobeats to regional Latin, indie folk, and bedroom pop-has expanded the scope of musical groups and solo acts. While pop, hip-hop, and electronic remain dominant in streaming, the virality-driven nature of social platforms has enabled niche genres to find dedicated global audiences. Cross-cultural collaborations and language diversity are reshaping mainstream trends, as seen in the growing prominence of multilingual tracks on global charts.

Geographically, artists from South Korea, Nigeria, India, and Latin America are rising to global stardom through digital-first discovery. Platforms such as YouTube Shorts, TikTok, and Reels play a crucial role in the breakout success of unsigned or indie acts. Meanwhile, live performance remains a key income source for artists, especially in post-pandemic recovery. Stadium tours, music festivals, and hybrid concerts (virtual + in-person) are returning with renewed commercial vigor.

Major artist development hubs-Los Angeles, London, Seoul, Lagos, and Berlin-continue to anchor the creative and commercial operations of global acts. At the same time, the artist diaspora and remote collaboration tools are decentralizing music creation, enabling pan-continental production networks. Synchronization opportunities in gaming, film, and advertising are also giving artists revenue avenues beyond streaming and ticketing.

What Is Fueling Growth in the Global Musical Groups and Artists Market?

The growth in the global musical groups and artists market is driven by several factors, including the disintegration of legacy music business models, the rise of streaming platforms, and the empowerment of artists through direct-to-fan channels. The creator economy is enabling musicians to build sustainable careers with diversified income streams-merchandise, sync licensing, branded content, fan subscriptions, and NFTs-beyond traditional royalties.

Technology is enabling artists to produce high-quality music with limited resources, distribute globally with the click of a button, and analyze real-time performance data to inform decisions. The rise of music social platforms and digital fan communities is fueling artist discovery, loyalty, and monetization at scale. Meanwhile, investment funds, music rights acquisitions, and venture capital in the artist economy are professionalizing independent careers and transforming artists into asset classes.

Live events and experiential music formats are bouncing back post-COVID, giving performers renewed momentum in fan engagement. Brands are increasingly partnering with musicians for co-branded campaigns, expanding the revenue base and cultural influence of artists. As boundaries between artist, influencer, and entrepreneur continue to blur, the market for musical groups and solo performers is poised to become even more expansive, dynamic, and commercially robust in the years ahead.

Report Scope

The report analyzes the Musical Groups and Artists market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Type (Music Festivals, Music Concerts, Music Shows, Other Types); Genre (Rock Genre, Pop Genre, EDM Genre, Other Genres); Revenue Source (Tickets Revenue, Sponsorship Revenue, Other Revenue Sources)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Music Festivals segment, which is expected to reach US$23.7 Billion by 2032 with a CAGR of a 8.3%. The Music Concerts segment is also set to grow at 8.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $8.0 Billion in 2025, and China, forecasted to grow at an impressive 12.0% CAGR to reach $10.9 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Musical Groups and Artists Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Musical Groups and Artists Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Musical Groups and Artists Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as AC/DC, Arctic Monkeys, Beyoncé, BLACKPINK, BTS and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Musical Groups and Artists market report include:

  • AC/DC
  • Arctic Monkeys
  • Beyoncé
  • BLACKPINK
  • BTS
  • Coldplay
  • Daddy Yankee
  • Dua Lipa
  • Ed Sheeran
  • Imagine Dragons
  • Justin Bieber
  • Lady Gaga
  • Linkin Park
  • Madonna
  • Metallica
  • Rammstein
  • Red Hot Chili Peppers
  • Rihanna
  • Shakira
  • The Rolling Stones

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Myeloproliferative Neoplasms Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Polycythemia Vera, Essential Thrombocythemia, and Myelofibrosis Drives MPN Drug Demand
  • OEM Focus on Targeted Therapies Supports Growth in JAK Inhibitor and Mutation-Specific Treatment Development
  • Increased Diagnosis Through Molecular Testing Boosts Early Intervention and Long-Term Treatment Planning
  • Expansion of Hematology-Oncology Care Infrastructure Enhances Access to Advanced Therapies in MPNs
  • Pipeline Advancements in CALR, MPL, and JAK2 Mutation Inhibitors Drive Innovation in Precision Oncology
  • Rising Demand for Oral Therapies and Home-Based Treatments Improves Patient Compliance and Quality of Life
  • Push for Combination Therapies Accelerates Clinical Trials Involving Immunomodulators and Anti-Fibrotic Agents
  • Regulatory Designations for Orphan Drugs and Breakthrough Therapies Support Fast-Tracked Development
  • Growth in Companion Diagnostic Platforms Enhances Selection of Personalized MPN Therapies
  • Increased Awareness Among Clinicians and Patients Expands Global Diagnosis and Treatment Rates
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Myeloproliferative Neoplasms Treatment Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Myeloproliferative Neoplasms Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Myeloproliferative Neoplasms Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Myeloproliferative Neoplasms Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Essential Thrombocythemia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Essential Thrombocythemia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Essential Thrombocythemia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Myelofibrosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Myelofibrosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Myelofibrosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Polycythemia Vera by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Polycythemia Vera by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Polycythemia Vera by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Tyrosine Kinase Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Tyrosine Kinase Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Tyrosine Kinase Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Janus Kinase Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Janus Kinase Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Janus Kinase Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Antimetabolites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Antimetabolites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Antimetabolites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Myeloproliferative Neoplasms Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Myeloproliferative Neoplasms Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Myeloproliferative Neoplasms Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Myeloproliferative Neoplasms Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Myeloproliferative Neoplasms Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Myeloproliferative Neoplasms Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Myeloproliferative Neoplasms Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Myeloproliferative Neoplasms Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
AUSTRALIA
  • Myeloproliferative Neoplasms Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Myeloproliferative Neoplasms Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Myeloproliferative Neoplasms Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Myeloproliferative Neoplasms Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Myeloproliferative Neoplasms Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AC/DC
  • Arctic Monkeys
  • Beyoncé
  • BLACKPINK
  • BTS
  • Coldplay
  • Daddy Yankee
  • Dua Lipa
  • Ed Sheeran
  • Imagine Dragons
  • Justin Bieber
  • Lady Gaga
  • Linkin Park
  • Madonna
  • Metallica
  • Rammstein
  • Red Hot Chili Peppers
  • Rihanna
  • Shakira
  • The Rolling Stones

Table Information